Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.
about
Regulation of Smad degradation and activity by Smurf2, an E3 ubiquitin ligasePhysical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A.Fibrochondrogenesis of hESCs: growth factor combinations and coculturesTransmembrane transforming growth factor-alpha tethers to the PDZ domain-containing, Golgi membrane-associated protein p59/GRASP55Inhibition of translation of transforming growth factor-beta 3 mRNA by its 5' untranslated regionThe crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor bindingRepression of bone morphogenetic protein and activin-inducible transcription by Evi-1TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3Transforming growth factor beta 1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferationTransforming growth factor beta 2 in epithelial differentiation of developing teeth and odontogenic tumors.TTRAP is a novel component of the non-canonical TRAF6-TAK1 TGF-β signaling pathwayCombinatorial association and abundance of components of interferon-stimulated gene factor 3 dictate the selectivity of interferon responses.Growth factors: roles in andrology.Direct activation of TACE-mediated ectodomain shedding by p38 MAP kinase regulates EGF receptor-dependent cell proliferation.Fibromodulin-deficiency alters temporospatial expression patterns of transforming growth factor-β ligands and receptors during adult mouse skin wound healing.The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300 are coactivators for smad3 in TGF-beta-induced transcriptional activation.Dog mastocytoma cells produce transforming growth factor beta 1Sequence specific protein binding to and activation of the TGF-beta 3 promoter through a repeated TCCC motifNeutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms.Induction and molecular signature of pathogenic TH17 cells.Regulation of bone morphogenetic protein activity by pro domains and proprotein convertases.The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation.A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterusTGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.Altered metabolic and adhesive properties and increased tumorigenesis associated with increased expression of transforming growth factor beta 1Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic developmentEnhanced translational efficiency of a novel transforming growth factor beta 3 mRNA in human breast cancer cells.Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein.Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene.Recombinant transforming growth factor type beta 3: biological activities and receptor-binding properties in isolated bone cellsSecretion and transcriptional regulation of transforming growth factor-beta 3 during myogenesis.Transforming growth factor-beta (TGF-beta) isoforms in rat liver regeneration: messenger RNA expression and activation of latent TGF-betaUmbilical cord transforming growth factor-beta 3: isolation, comparison with recombinant TGF-beta 3 and cellular localization.Transforming growth factor beta (TGFbeta1, TGFbeta2 and TGFbeta3) null-mutant phenotypes in embryonic gonadal development.The type I TGF-beta receptor is covalently modified and regulated by sumoylation.Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFbeta3): from laboratory discovery to clinical pharmaceutical.Avotermin: a novel antiscarring agent.Transforming growth factor-β3 (TGF-β3) knock-in ameliorates inflammation due to TGF-β1 deficiency while promoting glucose tolerance.TACE-mediated ectodomain shedding of the type I TGF-beta receptor downregulates TGF-beta signaling.
P2860
Q24290743-85D29322-A9D8-4673-838B-16D62AA196A2Q24522790-37F03528-B467-4C1E-BADA-358D988B5175Q24594539-18AF9254-B9ED-4B46-AE8F-EE2352B1D216Q24595955-E689DB35-037F-4A95-A540-5B21B813FEB7Q24597391-3363CF08-D382-45EA-BBF2-DCF06070D8CEQ24674065-0621BFF7-7479-4316-92C2-384D144B5213Q28246633-20D7AE5F-2A0A-4B69-A538-12EF8E3C6D24Q28364253-D1CA672E-8FE9-4175-8714-1A4B445F19D6Q33583459-9D1237E1-A286-49C1-9AF6-64CDD6B34D41Q33893414-DE025833-7AA1-4DD4-9F00-F6C5A75304F7Q34043345-CF4CEE43-250C-4504-B14D-0FDC08D59D7CQ34244880-7B89B506-BD2F-4079-A4D6-AF28F57A72B6Q34301608-0B4AAC31-D5DF-450D-B770-FF120A845C81Q34555877-7B75187A-087E-4BDB-982D-5B752AECA37FQ35112972-4CE17E6B-736E-446F-A380-E631AD2F2507Q35205960-8E578CFD-8311-4732-B887-262F2C794511Q35603298-DCB59642-C4E7-4581-801F-C67A0398C152Q35795410-C8C27426-9E7A-4A31-ACC5-CA3B77B3D667Q35830680-41E9DBB6-CAED-4635-841F-334E1DEBA2CDQ35840270-4C79E82A-1B3A-4BBA-AACA-2AFD47A84941Q36283752-228EB4CD-A5E6-4AEB-83BA-6DBF525F18D4Q36288112-27FF2207-CB74-486A-8A67-7CD258789703Q36327499-CB0772A8-4DA4-4E2D-9C03-FA07E0DD7640Q36353817-3625C442-9596-4156-94C2-6D5CBD955385Q36530713-F9688EFA-AFCE-4053-953C-5884D81A582EQ36531643-6B31AE5E-5A7A-4ABC-869D-2D2480CA5567Q36532922-7811B62D-C10E-49A7-9C0C-07811CF2387BQ36644133-0368F26A-8F6B-4A57-8CD8-E30BA7E80A9BQ36674035-9F59CE6B-EBFF-43E2-B238-1A71A8B0EF9CQ36679595-BD95AADB-8F2C-4F77-9A9F-D2C631D77A0EQ36722999-D574ABCF-534D-45E9-83E6-11D12AFCA612Q36726663-42220BDE-8DC8-48F0-ACB6-36F4AAD20659Q36745193-61792B2A-C1BD-448D-8B9C-A07300F429DEQ36837561-EA36741E-7333-4957-9C47-F65B668CCDB9Q36996177-6B8C6F04-0FE4-4F55-A36D-1EBB816A5264Q37112272-6DC46E6C-3498-45CE-BA05-2CA4C60EF5BAQ37222825-E479EFAC-384F-4A66-9E45-E6DA514DBD3CQ37256097-E8431076-220A-482C-A41E-0BC42D014A06Q37272232-68DB5AD0-310F-4B36-BD95-99D07216AF6FQ37340230-9AD554E9-EED5-4D1C-91F3-E741CA73C3F6
P2860
Human transforming growth factor-beta 3: recombinant expression, purification, and biological activities in comparison with transforming growth factors-beta 1 and -beta 2.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
Human transforming growth fact ...... th factors-beta 1 and -beta 2.
@en
type
label
Human transforming growth fact ...... th factors-beta 1 and -beta 2.
@en
prefLabel
Human transforming growth fact ...... th factors-beta 1 and -beta 2.
@en
P2093
P356
P1476
Human transforming growth fact ...... th factors-beta 1 and -beta 2.
@en
P2093
P304
P356
10.1210/MEND-3-12-1977
P577
1989-12-01T00:00:00Z